Suchergebnisse - "Immunoglobulins"

PubPharm (6.275)

71

Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors : a Chinese cross-sectional study

enthalten in: Scientific reports | 2024

von Tan, D. | Du, X. | Tang, J. | +11

72

SARS-CoV-2 Antibodies in Breastmilk Three and Six Months Postpartum in Relation to the Trimester of Maternal SARS-CoV-2 Infection-An Exploratory Study

enthalten in: International journal of molecular sciences | 2024

von Fich, L. | Christiansen, A. | Nilsson, A. | +6

73

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020-2022

enthalten in: Viruses | 2024

von Inoue, W. | Kimura, Y. | Okamoto, S. | +4

74

Serological markers and long COVID-A rapid systematic review

enthalten in: European journal of clinical investigation | 2024

von Collins, E. | Philippe, E. | Gravel, C. | +3

75

Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice

enthalten in: International immunopharmacology | 2024

von Kim, E. | Shin, J. | Ferrari, A. | +9

76

Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination

enthalten in: BMC medicine | 2024

von Martín Pérez, C. | Aguilar, R. | Jiménez, A. | +18

77

Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine

enthalten in: Journal of medical virology | 2024

von Huang, J. | Qiu, Y. | Luo, L. | +8

78

Reactogenicity and Peak Anti-RBD-S1 IgG Concentrations in Individuals with No Prior COVID-19 Infection Vaccinated with Different SARS-CoV-2 Vaccines

enthalten in: Laboratory medicine | 2024

von Milevoj Kopcinovic, L. | Unic, A. | Nikolac Gabaj, N. | +4

79

Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants : A randomized, observer-blinded, placebo-controlled phase 2 clinical trial

enthalten in: Vaccine | 2024

von Jin, F. | Qiu, Y. | Wu, Z. | +21

80

Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides

enthalten in: Journal of medical virology | 2024

von Kim, J. | Lee, J. | Kim, H. | +11